U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Primary Peritoneal Clear Cell Adenocarcinoma

MedGen UID:
1755695
•Concept ID:
C5421303
•
Neoplastic Process

Definition

The reemergence of primary peritoneal clear cell adenocarcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Primary Peritoneal Clear Cell Adenocarcinoma

Professional guidelines

PubMed

Treatment failure in endometrial carcinoma.
Huang HJ, Tang YH, Chou HH, Yang LY, Chao A, Huang YT, Lin G, Liu FY, Chang TC, Lai CH
Int J Gynecol Cancer 2014 Jun;24(5):885-93. doi: 10.1097/IGC.0000000000000131. PMID: 24819657
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article
Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review.
Thomas M, Mariani A, Wright JD, Madarek EO, Powell MA, Mutch DG, Podratz KC, Dowdy SC
Gynecol Oncol 2008 Feb;108(2):293-7. Epub 2007 Dec 21 doi: 10.1016/j.ygyno.2007.11.008. PMID: 18096208

Recent clinical studies

Etiology

Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study.
Ma X, Cao D, Zhou H, Wang T, Wang J, Zhang Y, Yu M, Cheng N, Peng P, Yang J, Huang H, Shen K
World J Surg Oncol 2023 Mar 27;21(1):106. doi: 10.1186/s12957-023-02992-0. PMID: 36973753Free PMC Article
Treatment failure in endometrial carcinoma.
Huang HJ, Tang YH, Chou HH, Yang LY, Chao A, Huang YT, Lin G, Liu FY, Chang TC, Lai CH
Int J Gynecol Cancer 2014 Jun;24(5):885-93. doi: 10.1097/IGC.0000000000000131. PMID: 24819657
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations.
Gallotta V, Fanfani F, Fagotti A, Chiantera V, Legge F, Gueli Alletti S, Nero C, Margariti AP, Papa V, Alfieri S, Ciccarone F, Scambia G, Ferrandina G
Ann Surg Oncol 2014 Jul;21(7):2369-75. Epub 2014 Feb 21 doi: 10.1245/s10434-014-3558-0. PMID: 24558070
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article
Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT, Rotmensch J, Yamada SD, Mundt AJ
Int J Radiat Oncol Biol Phys 2003 Apr 1;55(5):1272-6. doi: 10.1016/s0360-3016(02)04404-8. PMID: 12654437

Diagnosis

A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors.
Němejcová K, Bártů MK, Michálková R, Drozenová J, Fabian P, Fadare O, Hausnerová J, Laco J, Matěj R, Méhes G, Singh N, Stolnicu S, Škapa P, Švajdler M, Stružinská I, Cibula D, Kocian R, Lax SF, McCluggage WG, Dundr P
Diagn Pathol 2023 Feb 6;18(1):15. doi: 10.1186/s13000-023-01300-4. PMID: 36740684Free PMC Article
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
Lee M, Kim SW, Nam EJ, Cho H, Kim JH, Kim YT, Kim S
Yonsei Med J 2014 Nov;55(6):1664-71. doi: 10.3349/ymj.2014.55.6.1664. PMID: 25323906Free PMC Article
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations.
Gallotta V, Fanfani F, Fagotti A, Chiantera V, Legge F, Gueli Alletti S, Nero C, Margariti AP, Papa V, Alfieri S, Ciccarone F, Scambia G, Ferrandina G
Ann Surg Oncol 2014 Jul;21(7):2369-75. Epub 2014 Feb 21 doi: 10.1245/s10434-014-3558-0. PMID: 24558070
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article
Leiomyosarcoma with synchronous clear cell ovarian carcinoma.
Rettenmaier M, Epstein HD, Abaid LN, Bechtol KA, Goldstein BH
Onkologie 2010;33(12):695-7. Epub 2010 Nov 26 doi: 10.1159/000322216. PMID: 21124041

Therapy

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I
J Clin Oncol 2015 Dec 1;33(34):4015-22. Epub 2015 Sep 8 doi: 10.1200/JCO.2015.62.3397. PMID: 26351349
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
Lee M, Kim SW, Nam EJ, Cho H, Kim JH, Kim YT, Kim S
Yonsei Med J 2014 Nov;55(6):1664-71. doi: 10.3349/ymj.2014.55.6.1664. PMID: 25323906Free PMC Article
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article
Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review.
Thomas M, Mariani A, Wright JD, Madarek EO, Powell MA, Mutch DG, Podratz KC, Dowdy SC
Gynecol Oncol 2008 Feb;108(2):293-7. Epub 2007 Dec 21 doi: 10.1016/j.ygyno.2007.11.008. PMID: 18096208
Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT, Rotmensch J, Yamada SD, Mundt AJ
Int J Radiat Oncol Biol Phys 2003 Apr 1;55(5):1272-6. doi: 10.1016/s0360-3016(02)04404-8. PMID: 12654437

Prognosis

Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study.
Ma X, Cao D, Zhou H, Wang T, Wang J, Zhang Y, Yu M, Cheng N, Peng P, Yang J, Huang H, Shen K
World J Surg Oncol 2023 Mar 27;21(1):106. doi: 10.1186/s12957-023-02992-0. PMID: 36973753Free PMC Article
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
Lee M, Kim SW, Nam EJ, Cho H, Kim JH, Kim YT, Kim S
Yonsei Med J 2014 Nov;55(6):1664-71. doi: 10.3349/ymj.2014.55.6.1664. PMID: 25323906Free PMC Article
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerations.
Gallotta V, Fanfani F, Fagotti A, Chiantera V, Legge F, Gueli Alletti S, Nero C, Margariti AP, Papa V, Alfieri S, Ciccarone F, Scambia G, Ferrandina G
Ann Surg Oncol 2014 Jul;21(7):2369-75. Epub 2014 Feb 21 doi: 10.1245/s10434-014-3558-0. PMID: 24558070
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article
Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT, Rotmensch J, Yamada SD, Mundt AJ
Int J Radiat Oncol Biol Phys 2003 Apr 1;55(5):1272-6. doi: 10.1016/s0360-3016(02)04404-8. PMID: 12654437

Clinical prediction guides

Investigating the timing and site of recurrence for ovarian clear cell carcinoma: Analysis of the JGOG/GCIG trial-JGOG 3017-A3.
Yunokawa M, Kurihara N, Ishizuka N, Kanao H, Kajiyama H, Shimada M, Okamoto A, Aoki D, Sugiyama T, Enomoto T
Gynecol Oncol 2024 Nov;190:113-118. Epub 2024 Aug 22 doi: 10.1016/j.ygyno.2024.08.009. PMID: 39178526
Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study.
Ma X, Cao D, Zhou H, Wang T, Wang J, Zhang Y, Yu M, Cheng N, Peng P, Yang J, Huang H, Shen K
World J Surg Oncol 2023 Mar 27;21(1):106. doi: 10.1186/s12957-023-02992-0. PMID: 36973753Free PMC Article
A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors.
Němejcová K, Bártů MK, Michálková R, Drozenová J, Fabian P, Fadare O, Hausnerová J, Laco J, Matěj R, Méhes G, Singh N, Stolnicu S, Škapa P, Švajdler M, Stružinská I, Cibula D, Kocian R, Lax SF, McCluggage WG, Dundr P
Diagn Pathol 2023 Feb 6;18(1):15. doi: 10.1186/s13000-023-01300-4. PMID: 36740684Free PMC Article
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
Lee M, Kim SW, Nam EJ, Cho H, Kim JH, Kim YT, Kim S
Yonsei Med J 2014 Nov;55(6):1664-71. doi: 10.3349/ymj.2014.55.6.1664. PMID: 25323906Free PMC Article
Prognostic significance of rising serum CA-125 levels within the normal range in patients with epithelial ovarian, primary peritoneal, and tubal cancers, who, after initial treatment, had a complete clinical response.
Levy T, Weiser R, Boaz M, Shem EB, Golan A, Menczer J
Int J Gynecol Cancer 2012 Oct;22(8):1344-8. doi: 10.1097/IGC.0b013e3182691254. PMID: 22954785

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...